Long-term safety, high-resolution imaging, and tissue temperature modeling of subvisible diode micropulse photocoagulation for retinovascular macular edema

Retina

Volumn 32, Issue 2, 2012, Pages 375-386

  Luttrull, Jeffrey K ^a   Sramek, Christopher ^b   Palanker, Daniel ^b   Spink, Charles J ^a   Musch, David C ^c,d  

^a Private Practice   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Arrhenius integral; diabetic retinopathy; diode; laser; macular edema; micropulse; retinal photocoagulation; safety; subthreshold; subvisible; tissue temperature

Indexed keywords

ADULT; ARTICLE; AUTOFLUORESCENCE IMAGING; BRANCH RETINAL VEIN OCCLUSION; CONTROLLED STUDY; DIABETIC MACULAR EDEMA; DIABETIC RETINOPATHY; EYE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HUMAN; HYPERTHERMIA; INDOCYANINE GREEN ANGIOGRAPHY; INFRARED SPECTROMETRY; LASER COAGULATION; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; RETINA FOVEA; RETINA INJURY; SAFETY; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; SUBVISIBLE DIODE MICROPULSE PHOTOCOAGULATION; THERAPY EFFECT; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; BODY TEMPERATURE; DIABETIC RETINOPATHY; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; HUMANS; IATROGENIC DISEASE; LASER COAGULATION; LASERS, SEMICONDUCTOR; MACULAR EDEMA; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; PILOT PROJECTS; RETINA; RETINAL VEIN OCCLUSION; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY;

EID: 84856622953     PISSN: 0275004X     EISSN: 15392864     Source Type: Journal    
DOI: 10.1097/IAE.0b013e3182206f6c     Document Type: Article

References (70)

1. Kahn HA, Hiller R. Blindness caused by diabetic retinopathy. Am J Ophthalmol 1974;78:58-67.
2. Kahn HA, Bradley RF. Prevalence of diabetic retinopathy. Age, sex, and duration of diabetes. Br J Ophthalmol 1975;59: 345-349.
3. Aiello LM, Rand LI, Briones JC, et al. Diabetic retinopathy in Joslin Clinic patients with adult-onset diabetes. Ophthalmology 1981;88:619-623. (Pubitemid 11087720)
4. Klein R, Klein BE, Moss SE, et al. The Wisconsin Epidemiologic Study of diabetic retinopathy. XIV. Ten-year incidence and progression of diabetic retinopathy. Arch Ophthalmol 1994;112:1217-1228. (Pubitemid 24360961)
5. Preliminary report on the effects of photocoagulation therapy. Diabetic Retinopathy Study Research Group. Am J Ophthal-mol 1976;81:383-396.
6. Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Arch Ophthalmol 1985;103:1796-1806.
7. Friedlander SM, Welch RM. Vanishing disc neovascularization following intravitreal bevacizumab (avastin) injection. Arch Ophthalmol 2006;124:1365. (Pubitemid 44379881)
8. Jonas JB, Söfker A. Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema. Am J Ophthalmol 2001;132:425-427. (Pubitemid 32768624)
9. Diabetic Retinopathy Clinical Research Network, Elman MJ, Aiello LP, et al. Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology 2010;117: 1064-1077.
10. Diabetic Retinopathy Clinical Research Network (DRCR.net), Beck RW, Edwards AR, et al. Three-year follow-up of a randomized trial comparing focal/grid photocoagulation and intravitreal triamcinolone for diabetic macular edema. Arch Ophthalmol 2009;127:245-251.
11. Little HL. Complications of argon laser retinal photocoagulation : a five-year study. Int Ophthalmol Clin 1976;16:145-159.
12. Bughi S, Shaw S, Bessman A Laser damage to retinal ganglion cells. The effect on circadian rhythm. J Diabetes Complicat 2006: 184-187.
13. Olk RJ. Modified grid argon (blue-green) laser photocoagulation for diffuse diabetic macular edema. Ophthalmology 1986;93:938-950. (Pubitemid 16046104)
14. Olk RJ, Akuduman L. Minimal intensity diode laser (810 nm) photocoagulation (MIP) for diffuse diabetic macular edema (DDME). Semin Ophthalmol 2001;16:25-30. (Pubitemid 34132529)
15. Friberg TR, Karatza EC. The treatment of macular disease using a micropulsed and continuous wave 810 nm diode laser. Ophthalmology 1997;104:2030-2038. (Pubitemid 28053429)
16. Bandello F, Polito A, Del Borello M, et al. ''Light'' versus ''classic'' laser treatment for clinically significant macular oedema. Br J Ophthalmol 2005;89:864-870. (Pubitemid 40904811)
17. McHugh JDA, Marshall J, Ffytche TJ, et al. Initial clinical experience using a diode laser in the treatment of retinal vascular disease. Eye 1989;3:11-28.
18. Framme C, Walter A, Prahs P, et al. Structural changes of the retina after conventional laser photocoagulation and selective retina treatment (SRT) in spectral domain OCT. Curr Eye Res 2009;34:568-579.
19. Roider J, Brinkmann R, Wirbelauer C, et al. Retinal sparing by selective retinal pigment epithelial photocoagulation. Arch Ophthalmol 1999;117:1028-1034. (Pubitemid 29372935)
20. Elsner H, Pörksen E, Klatt C, et al. Selective retina therapy in patients with central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol 2006;244:1638-1645. (Pubitemid 44830824)
21. Framme C, Brinkmann R, Birngruber R, Roider J. Autofluorescence imaging after selective RPE laser treatment in macular diseases and clinical outcome: a pilot study. Br J Ophthalmol 2002;86:1099-1106.
22. Framme C, Walter A, Prahs P, et al. Comparison of threshold irradiances and online dosimetry for selective retina treatment (SRT) in patients treated with 200 nanoseconds and 1.7 microseconds laser pulses. Lasers Surg Med 2008;40:616-624.
23. Roider J, Michaud NA, Flotte TJ, et al. Response of the retinal pigment epithelium to selective photocoagulation. Arch Ophthalmol 1992;110:1786-1792.
24. Roider J, Brinkmann R, Wirbelauer C, et al. Retinal sparing by selective retinal pigment epithelial photocoagulation. Arch Ophthalmol 1999;117:1028-1034. (Pubitemid 29372935)
25. Paulus Y, Jain A, Nomoto H, et al. Selective retinal therapy with microsecond exposures using a continuous line scanning laser. Retina 2011;31:380-388.
26. Muqit M, Gray J, Marcellino GR, et al. Barely-visible 10 ms Pascal® laser photocoagulation for diabetic macular edema: observations of clinical effect and burn localization. Am J Ophthalmol 2010;149:974-986.
27. Squirrell DM, Stewart AW, Joondeph BC, et al. Large-spot subthreshold infrared laser to treat diabetic macular edema. Retina 2008;28:615-621. (Pubitemid 351589572)
28. Reichel E, Berrocal AM, Ip M, et al. Transpupillary ther-motherapy of occult subfoveal choroidal neovascularization in patients with age-related macular degeneration. Ophthalmology 1999;106:1908-1914.
29. Mainster MA, Reichel E. Transpupillary thermotherapy for age-related macular degeneration: principles and techniques. Semin Ophthalmol 2001;16:55-59. (Pubitemid 34326989)
30. Ahuja RM, Benner JD, Schwartz JC, et al. Efficacy of transpupillary thermotherapy (TTT) in the treatment of occult subfoveal choroidal neovascularization in age-related macular degeneration. Semin Ophthalmol 2001;16:81-85. (Pubitemid 34326993)
31. Newsom RS, McAlister JC, Saeed M, McHugh JD. Trans-pupillary thermotherapy (TTT) for the treatment of choroidal neovascularisation. Br J Ophthalmol 2001;85:173-178. (Pubitemid 32146756)
32. Pankratov MM. Pulsed delivery of laser energy in experimental thermal retinal photocoagulation. Proc Soc Photo Opt Instrum Eng 1990;1202:205-213.
33. Roider J, Hillenkamp F, Flotte T, et al. Microphotocoagulation: selective effects of repetitive short laser pulses. Proc Natl Acad Sci U S A 1993;90:8643-8647. (Pubitemid 23277726)
34. Brinkman R, Roider J, Birngruber R. Selective retina therapy (SRT): a review on methods, techniques, preclinical and first clinical results. Bull Soc Belge Ophtalmol 2006; (302):51-69.
35. Roider J, Michaud N, Flotte T, et al. Response of the RPE to selective photocoagulation of the RPE by repetitive short laser pulses. Arch Ophthalmol 1992;110:1786-1792.
36. Mason JO 3rd, Colagross CC, Feist RM, et al. Risk factors for severe vision loss immediately after transpupillary thermo-therapy for occult subfoveal choroidal neovascularization. Ophthalmic Surg Lasers Imaging 2008;39:460-465.
37. Roider J. Is there sufficient evidence to support transpupillary thermotherapy for age-related macular degeneration? Essentials of Ophthalmol 2005:67-72.
38. Sliney DH, Marshall J. Tissue specific damage to the retinal pigment epithelium: mechanisms and therapeutic implications. Lasers Light Ophthalmol 1992;5:17-28.
39. Friberg TR, Karatza EC. The treatment of macular disease using a micropulsed and continuous wave 810 nm diode laser. Ophthalmology 1997;104:2030-2038. (Pubitemid 28053429)
40. Moorman CM, Hamilton AM. Clinical applications of the MicroPulse diode laser. Eye 1999;13(pt 2):145-150. (Pubitemid 29210130)
41. Laursen ML, Moeller F, Sander B, Sjoelie AK. Subthreshold micropulse diode laser treatment in diabetic macular oedema. Br J Ophthalmol 2004;88:1173-1179. (Pubitemid 39141379)
42. Sivaprasad S, Sandhu R, Tandon A, et al. Subthreshold diode micropulse photocoagulation for clinically significant diabetic macular oedema: a three-year follow up. Clin Exp Ophthalmol 2007;35:640-644. (Pubitemid 47491221)
43. Nakamura Y, Mitamura Y, Arai M, et al. Functional and morphological changes of macula after subthreshold diode micropulse photocoagulation for diabetic macular oedema. Eye 2010;24:784-788.
44. Luttrull JK, Musch DC, Mainster MA. Subthreshold diode micropulse photocoagulation for the treatment of clinically significant diabetic macular oedema. Br J Ophthalmol 2005; 89:74-80. (Pubitemid 40040243)
45. Luttrull JK, Spink CA. Serial optical coherence tomography of subthreshold diode micropulse photocoagulation for diabetic macular edema. Ophthalmic Surg Lasers Imaging 2006;37: 370-377. (Pubitemid 44519241)
46. Luttrull JK, Musch DC, Spink CA. Subthreshold diode micropulse panretinal photocoagulation for proliferative diabetic retinopathy. Eye 2008;22:607-612. (Pubitemid 351712354)
47. Ohkoshi K, Yamaguchi T. Subthreshold diode laser photocoagulation for diabetic macular edema in Japanese patients. Am J Ophthalmol 2010;149:133-138.
48. Vujosevic S, Bottega E, Casciano M, et al. Microperimetry and fundus autofluorescence in diabetic macular edema. sub-threshold micropulse diode laser versus modified early treatment diabetic retinopathy study laser photocoagulation. Retina 2010;30:908-916.
49. Lavinsky D, Cardillo JA, Melo LA Jr, et al. Randomized clinical trial evaluating mETDRS versus normal or high-density micropulse photocoagulation for diabetic macular edema. Invest Ophthalmol Vis Sci. 2011 Feb 23. [Epub ahead of print].
50. Niemz M. Laser-Tissue Interactions: Fundamentals and Applications. Berlin: Springer; 2002.
51. Birngruber R, Hillenkamp F, Gabel VP. Theoretical investigations of laser thermal retinal injury. Health Physics 1985; 48:781-796. (Pubitemid 15025971)
52. Banerjee RK, Zhu L, Gopalakrishnan P, Kazmierczak MJ. Influence of laser parameters on selective retinal treatment using single-phase heat transfer analyses. Med Physics 2007;34: 1828-1841. (Pubitemid 46669177)
53. Sramek C, Paulus Y, Nomoto H, et al. Dynamics of retinal photocoagulation and rupture. J Biomed Optics 2009; 14:34007.
54. Sramek C, Mackanos M, Spitler R, et al. Non-damaging retinal phototherapy: dynamic range of heat shock protein expression. Invest Ophthalmol Vis Sci 2011;52:1780-1787.
55. Obana A, Lorenz B, Birngruber R. Transscleral and indirect ophthalmoscope diode laser retinal photocoagulation: experimental quantification of the therapeutic range for their application in the treatment of retinopathy of prematurity. Graefes Arch Clin Exp Ophthalmol 1993;231:378-383. (Pubitemid 23258533)
56. Early Treatment Diabetic Retinopathy Study Group. Case reports to accompany Early Treatment of Diabetic Retinop-athy Study Reports 3 and 4. Int Ophthalmol Clin 1987;27: 273-333.
57. Blankenship GW. Diabetic retinopathy, present and future. Conclusion of diabetic retinopathy symposium. Ophthalmology 1981;88:658-661. (Pubitemid 11087728)
58. Wolbarsht ML, Landers MB III. The rationale of photocoagulation therapy for proliferative diabetic retinopathy: a review and model. Ophthalmic Surg 1980;11:235-245. (Pubitemid 10088620)
59. Diabetic Retinopathy Research Study Group. Factors associated with visual outcome after photocoagulation for diabetic retinopathy. DRS Report Number 13. Invest Ophthalmol Vis Sci 1989;30: 23-28.
60. Mainster M. Decreasing retinal photocoagulation damage: principles and techniques. Semin Ophthalmol 1999;14: 200-209. (Pubitemid 30061162)
61. Early Treatment Diabetic Retinopathy Study Group. Early photocoagulation for diabetic retinopathy. ETDRS Report Number 9. Ophthalmology 1991;98: 766-785.
62. Early Treatment Diabetic Retinopathy Study Group. Photocoagulation for diabetic macular edema. ETDRS Report Number 4. Int Ophthalmol Clin 1987;27: 265-272.
63. Dorin G. Subthreshold and micropulse diode laser photocoagulation. Semin Ophthalmol 2003;18:147-153. (Pubitemid 38404840)
64. American National Standards Institute.American National Standard for the Safe Use of Lasers, ANSI Z136.1-2000. Washington, DC: American National Standards Institute, 2000.
65. Sliney DH, Wolbarsht ML. Safety with Lasers and Other Optical Sources: A Comprehensive Handbook. New York: Plenum Press; 1980:1035.
66. Sliney DH, Mellerio J, Gabel VP, et al. What is the meaning of threshold in laser injury experiments? Implications for human exposure limits. Health Phys 2002;82:335-347. (Pubitemid 34157534)
67. Miura Y, Treumer F, Klettner A, et al. VEGF and PEDF secretions over time following various laser irradiations on an RPE organ culture. Invest Ophthalmol Vis Sci 2010; 51:469.
68. Glaser BM, D'Amore PA, Michels RG, et al. The demonstration of angiogenic activity from ocular tissues. Preliminary report. Ophthalmology 1980;87:440-446. (Pubitemid 10102650)
69. Stellmach V, Crawford SE, Zhou W, Bouck N. Prevention of ischemia-induced retinopathy by the natural ocular antiangio-genic agent pigment epithelial-derived factor. Proc Natl Acad Sci U S A. 2001;98:2593-2597. (Pubitemid 32209527)
70. Flaxel C, Bradle J, Acott T, Samples JR. Retinal pigment epithelium produces matrix metalloproteinases after laser treatment. Retina 2007;27:629-634. (Pubitemid 46905156)